ProShares Ultra Nasdaq Biotechnology

(NASDAQ: BIB)
  • Trade now
  • Add to Watchlist
  • Get Chart
  • Print report
99.93 Up +0.70 +0.71%
Find snapshot for:
MORE ON BIB
QUICK STATS
Latest price 99.93 Change +0.70
Net assets 90.21 Mil % Change +0.71%
YTD +71.02 %
Category Specialty - Health
Fund family name ProShares
Index tracked S&P 500 TR USD
Inception date 04/06/2010
Turnover ratio +39.00 %
Detailed quote Last price update 05/23/2013 04:00 PM ET

OVERVIEW
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
MORNINGSTAR STYLE BOX
What is this?
Style Box for ETF
Long-Term Medium Quality Long-Term Medium Quality
Long-Term Medium Quality
ANNUAL RETURNS
2010 2011 2012
MKT NA 15.56 66.77
NAV NA 15.81 67.12
View additional performance information
MODERN PORTFOLIO THEORY STATISTICS
MEASUREMENT STANDARD INDEX
S&P 500 TR USD
R-Squared (1-year) 62
Beta (1-year) 1.87
Alpha (1-year) 19.69
DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

Ad Choice 
Feedback
ASSET ALLOCATION
Prospectus Objectives Specialty - Health
FEES AND EXPENSES
Expense Ratio 0.95%
Gross Expense Ratio 1.44%
Net Expense Ratio 0.95%
Management Fee 0.75%
VOLATILITY MEASURES
1-year standard deviation 35.59
Mean 3.69
3-year Sharpe ratio 1.24
3-year Treynor ratio 24.3